Double-blind trial of naftidrofuryl in the treatment of cerebral arteriosclerosis.
D000368:Aged; D002986:Clinical Trials as Topic; D004048:Diethylamines / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D005663:Furans / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy*; D008297:Male; D008568:Memory / Q000187:drug effects; D008570:Memory, Short-Term / Q000187:drug effects; D009281:Naphthalenes / Q000494:pharmacology / Q000627:therapeutic use; D010919:Placebos; D011422:Propionates / Q000494:pharmacology / Q000627:therapeutic use*; D012919:Social Behavior
D004048:Diethylamines; D005663:Furans; D009281:Naphthalenes; D010919:Placebos; D011422:Propionates